Hepatitis B therapies and antiviral resistance detection and management

Expert Review of Gastroenterology & Hepatology
Giselle HolnessDouglas T Dieterich

Abstract

Hepatitis B virus (HBV) infection is an important health problem and a major cause of chronic hepatitis that can lead to cirrhosis and hepatocellular carcinoma. Durable viral suppression has been documented to lower the risk of hepatocellular carcinoma and disease progression. Treatment of chronic HBV infection remains a major clinical challenge because long-term use with approved oral antiviral agents is associated with drug resistance. Antiviral resistance can result in poor clinical outcomes; therefore first-line therapy with the most potent agent(s) is recommended to lower the risk. Early detection of resistance is paramount to possibly reduce the risk of liver-related morbidity and mortality. It is important that clinicians monitor for therapeutic efficacy and resistance, so as to optimize the management of chronic HBV.

References

Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·M A NowakH McDade
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D D Richman
Dec 12, 2001·Alimentary Pharmacology & Therapeutics·H L ChanJ J Sung
Jul 9, 2003·European Journal of Biochemistry·Sung Gyoo ParkGuhung Jung
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florian van BömmelThomas Berg
Jul 1, 2005·The New England Journal of Medicine·George K K LauUNKNOWN Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group
Jan 13, 2006·Archives of Internal Medicine·Seng Gee LimUNKNOWN Emtricitabine FTCB-301 Study Group
Feb 4, 2006·Journal of Hepatology·Tim ShawStephen Locarnini
Mar 10, 2006·The New England Journal of Medicine·Ting-Tsung ChangUNKNOWN BEHoLD AI463022 Study Group
Mar 10, 2006·The New England Journal of Medicine·Ching-Lung LaiUNKNOWN BEHoLD AI463027 Study Group
Mar 15, 2006·Gastroenterology·Uchenna H IloejeUNKNOWN Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group
Nov 8, 2006·Gastroenterology·Stephanos J HadziyannisUNKNOWN Adefovir Dipivoxil 438 Study Group
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard J ColonnoDaniel J Tenney
Jan 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Irene RaptiStephanos J Hadziyannis
Jun 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S LokUNKNOWN Hepatitis B Virus Drug Resistance Working Group
Jul 17, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Emmet B KeeffeFabien Zoulim
Oct 3, 2007·Annals of Internal Medicine·Henry L Y ChanUNKNOWN 018 Study Group
Nov 6, 2007·Clinics in Liver Disease·Chien-Jen ChenHwai-I Yang
Dec 21, 2007·The New England Journal of Medicine·Ching-Lung LaiUNKNOWN Globe Study Group
Oct 11, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Emmet B KeeffeHillel Tobias
Nov 26, 2008·Gastroenterology·Yun-Fan LiawUNKNOWN GLOBE Study Group
Dec 5, 2008·The New England Journal of Medicine·Patrick MarcellinFranck Rousseau
Dec 5, 2008·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver
Mar 28, 2009·The Lancet Infectious Diseases·Man-Fung YuenChing-Lung Lai
Apr 1, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jung Im SeokDae-Seong Kim
Apr 17, 2009·World Journal of Gastroenterology : WJG·Emmet B Keeffe, Jean-François Rossignol
Apr 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norah A Terrault
May 30, 2009·Cleveland Clinic Journal of Medicine·Robert G Gish
Aug 12, 2009·Hepatology International·Yun-Fan LiawUNKNOWN Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver
Aug 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F Lok, Brian J McMahon
Sep 10, 2009·Gastroenterology·Fabien Zoulim, Stephen Locarnini

❮ Previous
Next ❯

Citations

Jun 15, 2012·Journal of Gastroenterology and Hepatology·Cheng WangJinlin Hou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

© 2022 Meta ULC. All rights reserved